# Edesa Biotech, Inc.: Form 8-K, filed May 15, 2026

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: 8-K
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 09:08 ET
- Period: 2026-05-13
- Accession: 0001171843-26-003459
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/f8k_051526.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/f8k_051526.htm

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-003459. Last ingested by Listed: Nov 5, 2026, 19:56 ET. No prices; not investment advice.